Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Thursday, August 30, 2012

Health Behavior News Service - Rising Cost of Inpatient Care Linked to Medical Devices and Supplies

Health Behavior News Service - Rising Cost of Inpatient Care Linked to Medical Devices and Supplies

By Glenda Fauntleroy, Contributing Writer
Research Source: Health Services Research
Health Behavior News Service
Inpatient hospital treatment accounts for the largest proportion of health care spending in the U.S., with the use of diagnostic imaging services such as MRIs, frequently implicated as the probable cause.  A new analysis finds that the biggest expense may not be imaging technology but from supplies including medical devices, such as stents and artificial joints. “One of the take-away messages for hospitals is that they should examine their own data in closer detail to explore the costs that are rapidly rising and have a better understanding for the underlying reasons,” said lead author Jared Lane Maeda, Ph.D., of Truven Health Analytics in Washington, D.C.

The study, released in Health Services Research, used the 2001 and 2006 Healthcare Cost and Utilization Project State Inpatient Databases and Medicare Cost Reports for community, non-rehabilitation hospitals in nine states. The researchers conducted a cost analysis on more than 10.2 million patient discharges for various conditions. 

At 24.2 percent of costs, “supplies and devices,” (defined as the “supply items required for patient care”) were the leading contributors to the increase in average cost per discharge. Intensive care unit charges contributed 17.6 percent, and room and board for a semiprivate room was 11.3 percent. Imaging, such as CT scans, and other advanced technological services contributed just 4.9 percent. The significant growth in the mean cost per discharge of supplies and devices suggests they should be examined more closely. 

Caroline Steinberg, vice president of Trends Analysis for the American Hospital Association, said the group supports comparative effectiveness research to determine whether new drugs and devices are both clinically and cost effective.  

“This is an area where more research is needed,” she added. “And as for increased use of the intensive care unit, that is consistent with the trend towards older and sicker patients.”

Maeda added that payers might consider negotiating discounts in areas of care and cost that are growing quickly
Article Discussion
» Ken Maddock 8/30/2012 10:22 AM
I'm glad that people are starting to focus on things other than the overuse of tests and provider inefficiency as the drivers of healthcare costs. While there is undoubtedly additional room for improvement in those areas, the costs providers have to pay for equipment, supplies, services, and software are a very large part of the reason for increased healthcare costs. Providers of equipment, supplies, services, and software charge what the market will bear, and the market will bear a lot because healthcare providers have few options, none of them inexpensive. It baffles me why so many people fail to see this as a problem. I want to be clear that I'm not opposed to those who provide services, equipment, software, and supplies making a profit. Obviously they need to make a profit to remain in business. It's the inequity between healthcare provider margins and supplier margins that have to be addressed somehow. The current model isn't sustainable.
» Joleen Chambers 8/30/2012 12:51 PM
I have been a Patient Advocate for the past four years. I have testified twice at FDA/CDRH Town Hall meetings (TX-3/10/11 and CA 9/22/11 about the high number of failed implanted medical devices. When these devices fail, they place patients in medical and legal purgatory because of poor federal public policy. The FDA approves most of them through 510(k) that does not require clinical testing or post-market follow up. The IOM report 7/29/11 stated that this practice must end. There is no product warranty and no objective information that allows patients to make a good decision. Furthermore, the device industry is powerful politically and has entitlements that prevent patients from accessing trial by jury and fair compensation. The FDA/CDRH Orthopedic Panel Patient Representative is non-voting.

# # #

TERMS OF USE: This story is protected by copyright. When reproducing any material, including interview excerpts, attribution to the Health Behavior News Service, part of the Center for Advancing Health, is required. While the information provided in this news story is from the latest peer-reviewed research, it is not intended to provide medical advice or treatment recommendations. For medical questions or concerns, please consult a health care provider.

Reach the Health Behavior News Service, part of the Center for Advancing Health, at or (202) 387-2829.

Health Services Research is the official journal of the Academy Health and is published by John Wiley & Sons, Inc. on behalf of the Health Research and Educational Trust. For information, contact Jennifer Shaw, HSR Business Manager at (312) 422 2646 or HSR is available online at

Maeda JL, Raetzman SO, Friedman BS. (2012). What hospital inpatient services contributed the most to the 2001 to 2006 growth in the cost per case? Health Services Research. Online Aug. 29.

No comments:

Post a Comment